Login / Signup

Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.

Yun-Yun XiongLiyuan WangYuesong PanMengxing WangLee H SchwammChunmiao DuanBruce C V CampbellShuya LiManjun HaoNa WuZhixin CaoShuangzhe WuZi-Xiao LiYong-Jun Wang
Published in: Stroke and vascular neurology (2024)
The risk-benefit profile of tenecteplase thrombolysis was preserved in the elderly patients, which lends further support to intravenous 0.25 mg/kg tenecteplase as an alternative to alteplase in these patients.
Keyphrases